Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended spectrum β-lactamase

Annals of Tropical Medicine and Parasitology

Volumn 104, Issue 3, 2010, Pages 271-274

  Matar, G M ^a   Dandache, I ^a   Carrer A ^b   Khairallah, M T ^a   Nordmann, P ^b   Sabra, A ^a   Araj, G F ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; OXA 48 ENZYME; TAZOBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; OXACILLINASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; LEBANON; NONHUMAN; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77952809640     PISSN: 00034983     EISSN: 13648594     Source Type: Journal    
DOI: 10.1179/136485910X12647085215651     Document Type: Article

References (12)

1. Aktas, Z., Kayacan, C. B., Schneider, I., Can, B., Midilli, K. & Bauernfeind, A. (2008). Chemotherapy, 54, 101-106.
2. Anon. (2005). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute.
3. Brown, D. F. J. & Brown, L. (1991). Journal of Antimicrobial Chemotherapy, 27, 185-190.
4. Carrër, A., Poirel, L., Eraksoy, H., Cagatay, A. A., Badur, S. & Nordmann, P. (2008). Antimicrobial Agents and Chemotherapy, 52, 2950-2954.
5. Carrër, A., Poirel, L., Yilmaz, M., Arikan Akan, O., Feriha, C., Cuzon, G., Matar, G. M., Honderlick, P. & Nordmann, P. (2010). Antimicrobial Agents and Chemotherapy, 54, 1312-1309.
6. Cuzon, G., Naas, T., Bogaerts, P., Glupczynski, Y., Huang, T. D. & Nordmann, P. (2008). Antimicrobial Agents and Chemotherapy, 52, 3463-3464.
7. Gülmez, D., Woodford, N., Palepou, M. F., Mushtaq, S., Metan, G., Yakupogullari, Y., Kocagoz, S., Uzun, O., Hascelik, G. & Livermore, D. M. (2008). International Journal of Antimicrobial Agents, 31, 523-526.
8. Kanj, S. S., Corkill, J. E., Kanafani, Z. E., Araj, G. A., Hart, C. A., Jaafar, R. & Matar, G. M. (2008). Clinical Microbiology and Infection, 14, 501-504.
9. Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J. & Carmeli, Y. (2007). Antimicrobial Agents and Chemotherapy, 51, 3026-3029.
10. Matar, G. M., Cuzon, G., Araj, G. F., Naas, T., Corkill, J., Kattar, M. M. & Nordmann, P. (2008). Clinical Microbiology and Infection, 14, 887-888.
11. Naas, T., Zerbib, M., Girlich, D. & Nordmann, P. (2003). Antimicrobial Agents and Chemotherapy, 47, 19-26.
12. Poirel, L., Pitout, J. D. & Nordmann, P. (2007). Future Microbiology, 2, 501-512.